| Name | Cvs Pharmacy #16138 |
|---|---|
| Organization Name | Grand St Paul Cvs Llc |
| Location | 2000 Cliff Lake Rd, Eagan, Minnesota 55122 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (651) 688-8947 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced interim results from a Phase I clinical trial of its investigational drug candidate, recombinant human Interleukin-7 (CYT107), in the treatment of post-transplant patients with T-cell depleted (TCD) bone marrow or peripheral blood stem cell transplants.
Veloxis Pharmaceuticals A/S today announced that it has submitted a Marketing Authorization Application to the European Medicines Agency seeking approval to market LCP-Tacro for the prevention of organ rejection in kidney transplant patients in the European Union.
Although gynecologic cancers account for only 10 percent of all new cancer cases in women, these cancers account for 20 percent of all female cancer survivors. Because long-term survival is now more common, it is increasingly important to detect recurrence.
Under-connectivity, or too few connections in the brain, is the underlying cause of brain disorders like autism and schizophrenia, according to a recent study from investigators at the George Washington University Institute for Neuroscience.
Women who have their breast cancers detected by physical examinations are at least twice as likely to undergo toxic treatments than those who have their cancer detected by mammography—regardless of the age of the woman, a new study shows.
› Verified 1 days ago
| NPI Number | 1225050909 |
| Organization Name | GRAND ST PAUL CVS LLC |
| Doing Business As | CVS PHARMACY #16138 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2000 Cliff Lake Rd, Eagan, MN 55122 |
| Phone Number | 651-688-8947 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced interim results from a Phase I clinical trial of its investigational drug candidate, recombinant human Interleukin-7 (CYT107), in the treatment of post-transplant patients with T-cell depleted (TCD) bone marrow or peripheral blood stem cell transplants.
Veloxis Pharmaceuticals A/S today announced that it has submitted a Marketing Authorization Application to the European Medicines Agency seeking approval to market LCP-Tacro for the prevention of organ rejection in kidney transplant patients in the European Union.
Although gynecologic cancers account for only 10 percent of all new cancer cases in women, these cancers account for 20 percent of all female cancer survivors. Because long-term survival is now more common, it is increasingly important to detect recurrence.
Under-connectivity, or too few connections in the brain, is the underlying cause of brain disorders like autism and schizophrenia, according to a recent study from investigators at the George Washington University Institute for Neuroscience.
Women who have their breast cancers detected by physical examinations are at least twice as likely to undergo toxic treatments than those who have their cancer detected by mammography—regardless of the age of the woman, a new study shows.
› Verified 1 days ago
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced interim results from a Phase I clinical trial of its investigational drug candidate, recombinant human Interleukin-7 (CYT107), in the treatment of post-transplant patients with T-cell depleted (TCD) bone marrow or peripheral blood stem cell transplants.
Veloxis Pharmaceuticals A/S today announced that it has submitted a Marketing Authorization Application to the European Medicines Agency seeking approval to market LCP-Tacro for the prevention of organ rejection in kidney transplant patients in the European Union.
Although gynecologic cancers account for only 10 percent of all new cancer cases in women, these cancers account for 20 percent of all female cancer survivors. Because long-term survival is now more common, it is increasingly important to detect recurrence.
Under-connectivity, or too few connections in the brain, is the underlying cause of brain disorders like autism and schizophrenia, according to a recent study from investigators at the George Washington University Institute for Neuroscience.
Women who have their breast cancers detected by physical examinations are at least twice as likely to undergo toxic treatments than those who have their cancer detected by mammography—regardless of the age of the woman, a new study shows.
› Verified 1 days ago
Cvs Pharmacy #06715 Type: Community/Retail Pharmacy Location: 4241 Jonny Cake Road, Eagan, Minnesota 55122 Phone: (651) 688-7041 | |
Cvs Pharmacy #16138 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2000 Cliff Lake Rd, Eagan, Minnesota 55122 Phone: (651) 688-8947 | |
Walgreens #5081 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4220 Lexington Ave S, Eagan, Minnesota 55123 Phone: (651) 686-1090 | |
Wal-mart Pharmacy 10-1786 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1360 Town Centre Dr, Eagan, Minnesota 55123 Phone: (651) 686-7431 | |
Hy-vee Pharmacy (1165) Type: Community/Retail Pharmacy Location: 1500 Central Park Commons Dr, Eagan, Minnesota 55121 Phone: (651) 405-3662 |